
GC34999
(S)-Ceralasertib
Also known as imino-methyl-[1-[6-[(3R)-3-methylmorpholin-4-yl]-2-(1H-pyrrolo[2,3-b]pyridin-4-yl)pyrimidin-4-yl]cyclopropyl]-oxo-lambda6-sulfane
(S)-Ceralasertib ((S)-AZD6738) is extracted from patent WO2011154737A1, Compound II, exhibits an IC50 of 2·578 nM·(S)-Ceralasertib is a potent and selective sulfoximine morpholinopyrimidine ATR inhibitor with excellent preclinical physicochemical and pharmacokinetic (PK) characteristics·(S)-Ceralasertib is developed improving aqueous solubility and eliminates CYP3A4 time-dependent inhibition
- CAS number
- 1352226-87-9
- Molecular weight
- 412.51
- Formula
- C20H24N6O2S
- Solubility
- Soluble in DMSO
- InChIKey
- OHUHVTCQTUDPIJ-MUWSIPGASA-N
- Catalogue number
- GC34999
- Brand
- GLPBIO
Computed properties PubChem CID 54761305 · XLogP 2.6 · TPSA 116 Ų · H-bond donors 2
- XLogP
- 2.6
- TPSA
- 116 Ų
- H-bond donors
- 2
- H-bond acceptors
- 7
- Rotatable bonds
- 4
- Heavy atoms
- 29
SMILES C[C@@H]1COCCN1C2=NC(=NC(=C2)C3(CC3)[S@@](=N)(=O)C)C4=C5C=CNC5=NC=C4
Computed descriptors from PubChem (CID 54761305), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il